Acorah Software Products - Accounts Production 15.0.600 false true 31 January 2023 1 February 2022 false 1 February 2023 31 January 2024 31 January 2024 06489173 Mr Nawab Qizilbash Ms Shahnaz Qizilbash iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 06489173 2023-01-31 06489173 2024-01-31 06489173 2023-02-01 2024-01-31 06489173 frs-core:CurrentFinancialInstruments 2024-01-31 06489173 frs-core:Non-currentFinancialInstruments 2024-01-31 06489173 frs-core:ComputerEquipment 2024-01-31 06489173 frs-core:ComputerEquipment 2023-02-01 2024-01-31 06489173 frs-core:ComputerEquipment 2023-01-31 06489173 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-02-01 2024-01-31 06489173 frs-core:FurnitureFittings 2024-01-31 06489173 frs-core:FurnitureFittings 2023-02-01 2024-01-31 06489173 frs-core:FurnitureFittings 2023-01-31 06489173 frs-core:OtherResidualIntangibleAssets 2024-01-31 06489173 frs-core:OtherResidualIntangibleAssets 2023-02-01 2024-01-31 06489173 frs-core:OtherResidualIntangibleAssets 2023-01-31 06489173 frs-core:ShareCapital 2024-01-31 06489173 frs-core:RetainedEarningsAccumulatedLosses 2024-01-31 06489173 frs-bus:PrivateLimitedCompanyLtd 2023-02-01 2024-01-31 06489173 frs-bus:FilletedAccounts 2023-02-01 2024-01-31 06489173 frs-bus:SmallEntities 2023-02-01 2024-01-31 06489173 frs-bus:AuditExempt-NoAccountantsReport 2023-02-01 2024-01-31 06489173 frs-bus:SmallCompaniesRegimeForAccounts 2023-02-01 2024-01-31 06489173 frs-bus:Director1 2023-02-01 2024-01-31 06489173 frs-bus:Director2 2023-02-01 2024-01-31 06489173 frs-core:CurrentFinancialInstruments 1 2024-01-31 06489173 frs-core:CurrentFinancialInstruments 2 2024-01-31 06489173 frs-core:CurrentFinancialInstruments 3 2024-01-31 06489173 frs-core:CurrentFinancialInstruments 4 2024-01-31 06489173 frs-countries:EnglandWales 2023-02-01 2024-01-31 06489173 2022-01-31 06489173 2023-01-31 06489173 2022-02-01 2023-01-31 06489173 frs-core:CurrentFinancialInstruments 2023-01-31 06489173 frs-core:Non-currentFinancialInstruments 2023-01-31 06489173 frs-core:ShareCapital 2023-01-31 06489173 frs-core:RetainedEarningsAccumulatedLosses 2023-01-31 06489173 frs-core:CurrentFinancialInstruments 1 2023-01-31 06489173 frs-core:CurrentFinancialInstruments 2 2023-01-31 06489173 frs-core:CurrentFinancialInstruments 3 2023-01-31 06489173 frs-core:CurrentFinancialInstruments 4 2023-01-31
Registered number: 06489173
Oxon Epidemiology Limited
Financial Statements
For The Year Ended 31 January 2024
TaxAssist Accountants
Screenworks, Office 218
22 Highbury Grove
London
N5 2EF
Financial Statements
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—6
Page 1
Balance Sheet
Registered number: 06489173
2024 2023
Notes £ £ £ £
FIXED ASSETS
Intangible Assets 4 57,115 68,538
57,115 68,538
CURRENT ASSETS
Debtors 6 2,376,425 1,970,934
Cash at bank and in hand 881,973 794,555
3,258,398 2,765,489
Creditors: Amounts Falling Due Within One Year 7 (520,398 ) (405,339 )
NET CURRENT ASSETS (LIABILITIES) 2,738,000 2,360,150
TOTAL ASSETS LESS CURRENT LIABILITIES 2,795,115 2,428,688
Creditors: Amounts Falling Due After More Than One Year 8 (1,166,055 ) (760,893 )
NET ASSETS 1,629,060 1,667,795
CAPITAL AND RESERVES
Called up share capital 9 2 2
Profit and Loss Account 1,629,058 1,667,793
SHAREHOLDERS' FUNDS 1,629,060 1,667,795
Page 1
Page 2
For the year ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Nawab Qizilbash
Director
21 October 2024
The notes on pages 3 to 6 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Oxon Epidemiology Limited is a private company, limited by shares, incorporated in England & Wales, registered number 06489173 . The registered office is 200 Northcote Road, London, E17 7DH.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.3. Intangible Fixed Assets and Amortisation - Other Intangible
Other intangible assets are EDC Software. It is amortised to profit and loss account over its estimated economic life of 10 years.
2.4. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Fixtures & Fittings 25% reducing balance
Computer Equipment 33.33% straight line
2.5. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
Page 3
Page 4
2.6. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 6 (2023: 5)
6 5
4. Intangible Assets
Other
£
Cost
As at 1 February 2023 114,230
As at 31 January 2024 114,230
Amortisation
As at 1 February 2023 45,692
Provided during the period 11,423
As at 31 January 2024 57,115
Net Book Value
As at 31 January 2024 57,115
As at 1 February 2023 68,538
Page 4
Page 5
5. Tangible Assets
Fixtures & Fittings Computer Equipment Total
£ £ £
Cost
As at 1 February 2023 704 39,332 40,036
As at 31 January 2024 704 39,332 40,036
Depreciation
As at 1 February 2023 704 39,332 40,036
As at 31 January 2024 704 39,332 40,036
Net Book Value
As at 31 January 2024 - - -
As at 1 February 2023 - - -
6. Debtors
2024 2023
£ £
Due within one year
Trade debtors 1,415,214 971,997
Receivable from Oxon Spain 839,661 880,287
Corporation tax recoverable assets 121,550 118,650
2,376,425 1,970,934
7. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Trade creditors 77,498 21,722
Bank loans and overdrafts - 10,127
PAYE 3,131 3,091
VAT 180,932 33,386
Net wages - 648
Pension Control Account 2,981 2,845
Other creditors- DCD Trustee Loan 30,653 91,027
Other Loan- BBL current portion 10,000 10,000
Accruals 4,186 3,684
Directors' loan accounts 211,017 228,809
520,398 405,339
Page 5
Page 6
8. Creditors: Amounts Falling Due After More Than One Year
2024 2023
£ £
BBL 13,333 23,333
Deferred income- PTC 1,152,722 737,560
1,166,055 760,893
9. Share Capital
2024 2023
£ £
Allotted, Called up and fully paid 2 2
Page 6